Skip to main content

KraneShares MSCI All China Health Care Index ETF (KURE)

NYSEARCA: KURE · IEX Real-Time Price · USD
36.82 -0.34 (-0.91%)
Sep 24, 2021 4:00 PM EDT - Market closed
Assets$217.15M
NAV$37.12
Expense Ratio0.65%
PE Ratio37.27
Shares Out5.85M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend DateDec 27, 2019
1-Year Return
-
Volume18,718
Open36.94
Previous Close37.16
Day's Range36.75 - 37.16
52-Week Low32.60
52-Week High47.69
Beta0.60
Holdings98
Inception DateFeb 1, 2018

About KURE

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index. The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

Asset ClassEquity
RegionAsia-Pacific
IssuerKraneShares
Stock ExchangeNYSEARCA
Ticker SymbolKURE
Index TrackedMSCI China All Shares Health Care 10/40 Index

Top 10 Holdings

43.08% of assets
NameSymbolWeight
WuXi Biologics (Cayman) Inc2269.HK9.44%
Shenzhen Mindray Bio-Medical Electronics Co Ltd300760.SZ5.69%
Wuxi AppTec Co Ltd Class A603259.SS4.82%
BeiGeneBGNE4.45%
Jiangsu Hengrui Pharmaceuticals Co Ltd600276.SS3.88%
Aier Eye Hospital Group Co Ltd300015.SZ3.60%
Chongqing Zhifei Biological Products Co Ltd300122.SZ2.98%
CSPC Pharmaceutical Group Ltd1093.HK2.87%
Innovent Biologics Inc1801.HK2.79%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd600436.SS2.56%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 29, 2020$0.000109Dec 31, 2020
Dec 27, 2019$0.057325Dec 31, 2019
Dec 26, 2018$0.039344Dec 28, 2018
Full Dividend History

News

A KURE-All for Bland Healthcare Exposure

In some form or fashion, hundreds of exchange traded funds offer exposure to Chinese equities. As the world's second-largest country has evolved, so have the related ETF offerings.

4 months ago - ETF Trends

Healthcare Gains Drive Chinese Stocks Even Higher

Asian markets ended last week up, buoyed in part by a rally in healthcare firms, according to Reuters. The blue-chip CSI300 Index, which tracks the top 300 stocks traded on the Shenzhen Stock Exchange a...

4 months ago - ETF Trends

Cover All the Hot Bases in Chinese Equity with This Model Portfolio

ETF investors looking for growth and innovation in China, can turn to the KraneShares Krane China Innovation Strategy. The strategy consists of a model portfolio that seeks to provide investors exposure...

Other symbols:KFVGKGRNKSTRKWEB
4 months ago - ETF Trends

5 Top-Performing ETFs of Last Week

Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.

Other symbols:CHBCHIHEPU
4 months ago - Zacks Investment Research

Best-Performing ETF Areas of Last Week

Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.

Other symbols:BDRYCHNATAN
5 months ago - Zacks Investment Research

Is Chinese Healthcare the Miracle KURE for Your Portfolio?

In the United States, healthcare is a dynamic sector home to defensive value stocks, disruptive growth names, and plenty of in-between. China offers a comparable level of healthcare dynamism, which inve...

5 months ago - ETF Trends

Best Pharmaceutical ETFs for Q2 2021

The best pharmaceutical ETFs for Q2 2021 are KURE, MJJ, and POTX.

Other symbols:POTX
7 months ago - Investopedia

Top ETF Areas of Last Week

The markets rallied because Biden started his term by signing a number of executive orders to counter the ill effects of the COVID-19 pandemic, empower environmental protection initiatives and roll back...

8 months ago - Zacks Investment Research

Best Healthcare ETFs for Q1 2021

The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.

Other symbols:ARKGPTH
10 months ago - Investopedia

Best Pharmaceutical ETFs for Q1 2021

The best pharmaceutical ETFs for Q1 2021 are KURE, XPH, and IHE.

Other symbols:IHEXPH
10 months ago - Investopedia

Chinese stocks have biggest gains in 3 months

Yahoo Finance's Tom Belger reports on the latest stock news from China and Europe.

Other symbols:CNXTKWEB
11 months ago - Yahoo Finance

COVID Impact Varies Across Emerging Market ETFs

Emerging markets have been hit hard by coronavirus, but some were hit harder than others.

1 year ago - ETFcom

Best Healthcare ETFs for Q4 2020

The best healthcare ETFs for Q4 2020 are ARKG, KURE, and PTH.

Other symbols:ARKGPTH
1 year ago - Investopedia

Best Pharmaceutical ETFs for Q4 2020

The best pharmaceutical ETFs for Q4 2020 are KURE, XPH, and PJP.

Other symbols:PJPXPH
1 year ago - Investopedia

Top 10 Sector ETFs on the Market Today

Sector ETFs and industry funds are different. The 11 sectors addressed in the S&P 500 are as follows (in order of weight in the index): technology, healthcare, consumer discretionary, communication serv...

1 year ago - InvestorPlace

5 Reasons to Bet on China ETFs

The Chinese economy returned to growth in the second quarter of 2020. This along with PBOC's targeted policy easing and China's solid tech industry make China investing winners in the recent trading ses...

Other symbols:ASHSCHISCNXT
1 year ago - Zacks Investment Research

6 China ETFs From 3 Sectors That Emerged Winners in June

A host of China ETFs outperformed in June. These funds come mainly from the technology, healthcare and clean energy segments.

Other symbols:CHIHCHIKCQQQKGRNKWEB
1 year ago - Zacks Investment Research

7 Healthcare ETFs Which Should Continue Growing Into 2021

Between the novel coronavirus and an election year, these healthcare ETFs appear poised to post strong growth into 2021.

Other symbols:ARKGFHLCIHIPTHRYHXHE
1 year ago - InvestorPlace

7 Emerging Markets ETFs for Adventurous Investors

In theory, blaming the emerging markets malaise on China because the country was the initial epicenter of the coronavirus appears to make sense. However, that argument doesn't hold water because the MSC...

1 year ago - InvestorPlace

3 Best Country ETFs of 1H That Survived the Pandemic

While most the countries' stocks have been beaten down badly in the pandemic, some still managed to trade in green for the first half of the year.

Other symbols:EDENIZRL
1 year ago - Zacks Investment Research

China Healthcare ETF (KURE) Hits New 52-Week High

The fund hit a 52-week high lately. Can this go further higher?

1 year ago - Zacks Investment Research

6 Equity ETFs in Green Last Week Despite Wall Street Bloodbath

Overall, the S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 added 4.8%, 5.6%, 1.6%, and 7.9% last week, respectively.

Other symbols:CLIXESPOHERDHERORING
1 year ago - Zacks Investment Research

Best Performing Pharmaceutical ETFs for Q3 2020

The best pharmaceutical ETFs for Q3 2020 are KURE, XPH, and PPH.

Other symbols:PPHXPH
1 year ago - Investopedia

Best-Performing Healthcare ETFs for Q3 2020

The best Healthcare ETFs for Q3 2020 are ARKG, KURE, and PTH.

Other symbols:ARKGPTH
1 year ago - Investopedia

Healthcare ETFs Are Shining in China, Too

Healthcare stocks and ETFs are outperforming the broader market this year, but as the KraneShares MSCI All China Health Care Indes ETF (KURE) proves, that theme isn’t confined to the U.S. KURE invests i...

1 year ago - ETF Trends